|
1 |
The Role of Innate Immunity on the Adaptive Immunopathogenesis of Asthma
Kim, Yoon-Keun;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.12, no.1, pp.3-12,
|
|
2 |
Introduction of Electronic Adverse Event Reporting System
Kim, Ok-Gu;Park, Byung-Joo;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.12, no.1, pp.13-15,
|
|
3 |
Pharmacokinetic/Pharmacodynamic Model for the Time Course of Myelosuppression of New Anticancer Drug (CKD-602)
Yi, So-Young;Bae, Kyun-Seop;Cho, Joo-Youn;Yu, Kyung-Sang;Lim, Hyeong-Seok;Chung, Jae-Yong;Hong, Kyoung-Sup;Bang, Yung-Jue;Shin, Sang-Goo;Jang, In-Jin;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.12, no.1, pp.16-26,
|
|
4 |
Evaluation of Herb-drug Interaction in Healthy Subjects by Comparing the Cytochrome P450 Activities before and after Multiple Administrations of Herbal Medicines
Oh, Dal-Seok;Yu, Kyung-Sang;Cho, Joo-Youn;Yi, So-Young;Lim, Hyeong-Seok;Chung, Jae-Yong;Kim, Jung-Ryul;Chung, Hye-Ryung;Kim, Ho-Cheol;Shin, Sang-Goo;Jang, In-Jin;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.12, no.1, pp.27-38,
|
|
5 |
Prescription Patterns of COX-2 Selective Inhibitor by Changes of Claims Review Criteria
Choi, Nam-Kyong;Park, Ki-Dong;Sung, Ju-Hun;Lee, Seung-Mi;Kim, Yoon-I;Choi, Ji-Sook;Kim, Hwa-Jung;Park, Byung-Joo;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.12, no.1, pp.39-46,
|
|
6 |
Pharmacokinetics and Pharmacodynamics of Fexofenadine in Relation to Genetic Polymorphism of MDR-1 C3435T/G2677T
Shon, Ji-Hong;Kim, Tae-Jin;Lee, Sang-Seop;Liu, Kwang-Hyun;Yoon, Young-Ran;Cha, In-Jun;Shin, Jae-Gook;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.12, no.1, pp.47-56,
|
|
7 |
A 8weeks, Double blind, Randomized Comparative Clinical Trial Comparing The Efficacy and Safety between UDB and DDB for Chonic Hepatitis : Phase III Study
Son, Dong-Kyun;Cheung, Dae-Young;Chang, U-Im;Park, Soo-Heon;Yang, Jin-Mo;Han, Joon-Yeol;Chung, Kyu-Won;Sun, Hee-Sik;Kim, Jae-Kwang;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.12, no.1, pp.57-66,
|
|